Neonatal Guidelines. Chapter 15: Pharmacy related Version: Date Revised: 24 th January 2017

Size: px
Start display at page:

Download "Neonatal Guidelines. Chapter 15: Pharmacy related Version: Date Revised: 24 th January 2017"

Transcription

1 Neonatal Guidelines Chapter 15: Pharmacy related Version: Specialty: Neonatal Medicine Revised by: Katherine Wilson Edited by: Sujoy Banerjee Date Revised: 24 th January 2017 Approved by: ABMU Joint Perinatal Forum Date Ratified: 6 th February 2017 Date of implementation 1 st March 2017 Date for Review: 1 st March

2 Directorate of Child Health Checklist for Clinical Guidelines being submitted for Approval by ABMU Joint Perinatal Forum Title of Guideline: Name(s) of revision author: Chair of Group or Committee supporting submission: Katherine Willson; Edited :Sujoy Banerjee Neonatal Guideline Group Sujoy Banerjee Issue / Version No: Next Review / Guideline Expiry: Review date: 1 st March 2020 Details of persons included in consultation process: Neonatal Consultants, Neonatal junior doctors, Nursing Managers, Neonatal Pharmacist Brief outline giving reasons for document being submitted for ratification Routine Revision Name of Pharmacist (mandatory if drugs involved): Please list any policies/guidelines this document will supercede: Katherine Willson Chapter 15: Pharmacy related v th September 2015 Keywords linked to document: Pharmacy, drugs, formulary, neonate Date approved by ABMU Joint Perinatal Forum: 6 th February 2015 File Name: Used to locate where file is stores on hard drive 2

3 New guidance on Changes included in the latest revision v Clonidine 2. Peripheral dopamine 3. Hydrocortisone for Chronic Lung Disease Minor modification on 1. IV Midazolam 2. Dexamethasone 3. Dobutamine 4. Tazocin 3

4 Topics CONTENTS Page number Aciclovir 5 Adrenaline 6 Bicarbonate 7 Calcium gluconate 9 Clonazepam 10 Clonidine 11 Dexamethasone 12 (Dinoprostone)Prostaglandin E2 13 Dobutamine 14 Dopamine 16 Dopamine by peripheral route 17 Heparin 18 Hydrocortisone 19 Insulin 20 Liver medication for conjugated jaundice 21 Levetiracetam 22 Magnesium Sulphate 23 Midazolam 25 Morphine 26 Noradrenaline 28 Tazocin 29 THAM 30 Vecuronium 31 4

5 ACICLOVIR Treatment and prophylaxis of herpes simplex and varicella zoster infection 10-20mg/kg iv every 8 hours Infusion given over 1 hour PREPARATIONS: Aciclovir infusion 250mg in 10ml DILUTION: Dilute to a concentration of at least 5mg in 1ml before administration DILUENTS: Glucose 5% Sodium chloride 0.9% KNOWN COMPATIBILITY: KNOWN INCOMPATIBILITIES: Cefotaxime, Ceftazidime,Fluconazole, Gentamicin, Heparin, Imepenem, Metronidazole, Potassium, Ranitidine, Vancomycin Dobutamine, Dopamine, Meropenem,Morphine, Tazocin 5

6 ADRENALINE Inotrope VIA A CENTRAL LINE Initially nanograms /kg/minute up to a maximum of 1.5micrograms/kg/minute PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000) DILUTION: Weight in Kg x1.5= mg of adrenaline made up to 25ml with 10% dextrose 0.1ml /hour = 100nanogram/kg/minute DILUENTS: Dextrose 5%,Dextrose 10%, Sodium Chloride 0.9% KNOWN COMPATIBILITY: Calcium Salts, Dopamine,Dobutamine,Doxapram,Fentanyl,Frusemide, Heparin,Insulin,Midazolam,Milrinone,Morphine,Noradrenaline, Pancuronium,Potassium Chloride,Ranitidine,TPN, Vecuronium KNOWN INCOMPATIBILITIES: Lipid, Lignocaine, Sodium bicarbonate 6

7 Sodium Bicarbonate Half correction for Metabolic acidosis: Base deficit (mmol/l) x body weight (Kg) x 0.3 = mmol of bicarbonate required 4.2% sodium bicarbonate contains 0.5 mmol bicarbonate / ml. Always try to correct the underlying condition leading to metabolic acidosis. The correction if necessary, should ideally be undertaken over several hours as a slow infusion. This correction will always undercorrect the acidaemia but is usually sufficient. THAM is an alternative base. It has the advantage of being sodium free and shouldn t raise the PaCO 2. Therefore this may be preferred if the baby has very high sodium or PaCO 2. However it stops premature babies breathing so should only be used in babies who are being ventilated. 1 ml of 7.2% THAM is approx equivalent to 1 mmol bicarbonate. Bicarbonate infusion through arterial line in extremely premature babies (<26 weeks gestation): Extremely preterm neonates (<26/40 weeks) can be anticipated to develop a metabolic acidosis. This can be due to renal tubular loss of bicarbonate accompanied by chloride retention leading to a hyperchloremic metabolic acidosis. In the short term, metabolic acidosis is associated with the following abnormalities: Inhibition of surfactant production Increases in pulmonary vascular resistance Reduction in cardiac output Abnormal EEGs (consequences unclear) In the longer term, a ph <7.2 is associated with an abnormal neurodevelopmental outcome in preterm neonates <1000g. Metabolic acidosis is predominantly corrected by identifying its cause. Whether correction of metabolic acidosis improves outcome has not been studied in a randomised trial. 7

8 However, if bicarbonate treatment is given, it is best administered slowly. Twenty-four hour intravenous infusions are associated with decreased mortality, whereas rapid infusions are associated with an increased incidence of IVH. 5 Hence, prophylactic arterial infusion of low dose bicarbonate in this high risk population is established clinical management in many UK neonatal units. Route: Dose: Preparation: Bicarbonate should be infused through a UA or peripheral arterial line. 0.54mmols of NaHCO 3 administered per 24-hours (or about 1mmol/kg/day for a 500g neonate). 3mls of 4.2% NaHCO 3 (=1.5mmol) 16mls of sterile water for injection 1ml of hepsaline equivalent to 10 iu of heparin Total volume 20 mls with heparin conc. of 0.5 i.u/ml Infusion rate: Run solution at 0.3ml/hr Use a three way tap in between the baby and the transducer to infuse continuous bicarbonate solution as above through the side arm (Transducer set in a normal way with 0.45% hepsaline attached but not infusing from the syringe). During sampling stop bicarbonate infusion, sample in the usual way and flush with hepsaline from the syringe. Once flushed restart bicarbonate solution. 8

9 CALCIUM GLUCONATE Hypocalcaemia Urgent IV Correction 200mg/kg calcium gluconate 2ml/kg calcium gluconate 10% Maintenance 0.5mmol/kg/24hours calcium 2.5ml/kg/24hours calcium gluconate10% PREPARATIONS: Calcium Gluconate 10% 100mg calcium gluconate in 1ml 0.22mmol calcium in 1ml DILUTION: Urgent Correction Slow IV injection over 5-10minutes Continuous infusion Dilute dose required 10 fold Maximum administration rate 22micromol/kg/hour DILUENTS: Dextrose 5% Dextrose 10% Sodium Chloride 0.9% KNOWN COMPATIBILITY: Adrenaline, Heparin, Midazolam, Noradrenaline, Potassium Chloride 9

10 CLONAZEPAM Anticonvulsant IV Bolus 100microgram/kg/day over 30mins IV Infusion Initially 50microgram/kg THEN 10microgram/kg/hour adjustedaccording to response (Max 60microgram/kg/hour) PREPARATIONS: DILUTION: Clonazepam 1mg in 1ml supplied with a further 1ml ampoule water for injection. Mix immediately before use IV BOLUS Dilute dose to 100microgram in 1ml IV INFUSION (Weight in grams x0.5)=micrograms of clonazepam made up to 50ml with 5% dextrose 1ml/hr=10micrograms/kg/hour Administer in NON PVC containers Expiry 12 hours DILUENTS: Dextrose 5% Dextrose 10% Sodium chloride 0.9% KNOWN COMPATIBILITY: KNOWN INCOMPATIBILITIES: None Sodium bicarbonate 10

11 Drug: Clonidine Use: Sedation/Opiate withdrawal Dosage: Orally 3 microgram/kg/dose three times daily, can be increased upto 5 microgram/kg/dose TDS Weaning: Can be stopped immediately if used for < 2 weeks. If used for > 2 weeks, reduce daily over 5 days by 1 microgram/kg/dose (i.e. 5,4,3,2,1) tds then stop Preparation : Clonidine Hydrochloride ( 10 microgram in 1 ml) oral Solution Note : Close cardiovascular monitoring especially baby s blood pressure ( hourly for first 6 hours, 2 hourly over next 6 hours, then 4 hourly over next 12 hours.) 11

12 PREPARATIONS: DEXAMETHASONE Treatment of chronic lung disease 60mcg/kg bd day1-3 40mcg/kg bd day4-6 20mcg/kg bd day7-8 8mcg/kg bd day 9-10 Doses given are as dexamethasone base DEXAMETHASONE 3.3mg in 1ml (Hameln) This is 3.3mg/ml dexamethasone base DILUTION: Take 0.3ml and dilute to 10ml with 5% dextrose to give a solution containing 100microgram/ml dexamethasone base. Give as infusion over minimum of 5-10mins DILUENTS: Dextrose 5% Sodium Chloride 0.9% KNOWN COMPATIBILITY: Aciclovir, Heparin, Morphine, Potassium, Ranitidine, KNOWN INCOMPATIBILITIES: Ciprofloxacin, Midazolam, Vancomycin 12

13 DINOPROSTONE (Prostagandin E2) Maintain patency of ductus arteriosus Initially 5nanograms/kg/minute up to a maximum of 40nanogram/kg/minute PREPARATIONS: 0.75ml ampoule containing 1mg in 1ml DILUTION: For 5nanogram/kg/minute Add 0.5ml(500microgram) to 500ml of 10% glucose to give a solution of 1microgram in 1ml. Infuse at 0.3ml/kg/hour DILUENTS: Dextrose 5% Dextrose 10% KNOWN COMPATIBILITY: None KNOWN INCOMPATIBILITIES: VERY UNSTABLE do not use with any other drugs 13

14 PREPARATIONS: DILUTION: DOBUTAMINE Inotrope 5-20micrograms/kg/minute by continuous infusion Concentrations above 5mg in 1ml must be given centrally Dobutamine 250mg in 20ml (12.5mg in 1ml) SINGLE STRENGTH (Weight in Kgx30)=mg dobutamine made up to 50ml with 5% or 10% dextrose 0.2-2ml/hour=2-20microgram/kg/minute DOUBLE STRENGTH (Weight in Kg x30)=mg dobutamine made up to 25ml with 5% or 10% dextrose 0.1-1ml/hour =2-20microgram/kg/minute QUADRUPLE STRENGTH (Weight in Kg x30)=mg dobutamine made up to 12.5ml with 5% or 10% dextrose ml/hour=4-20microgram/kg/minute DILUENTS: KNOWN COMPATIBILITY: Dextrose5%, Dextose10% Sodium chloride 0.9% Adrenaline, amiodarone, dopamine, fentanyl, lignocaine, morphine, noradrenaline, pancuronium, potassium, ranitidine 14

15 KNOWN INCOMPATIBILITIES: Aciclovir, calcium gluconate, digoxin, frusemide, heparin, indomethacin, magnesium sulphate, phenytoin, sodium bicarbonate, Tazocin 15

16 PREPARATIONS: DOPAMINE Inotrope 2-20micrograms/kg/minute by continuous iv infusion Dopamine Hydrochloride 200mg in 5ml DILUTION: SINGLE STRENGTH (Weight in Kg x30) = mg dopamine made up to 50ml with 5% or 10% dextrose 0.2-2ml/hour = 2-20 microgram/kg/minute DOUBLE STRENGTH (Weight in Kg x30) = mg dopamine made up to 25ml with 5% or 10% dextrose 0.1-1ml/hour= 2-20 microgram/kg/minute QUADRUPLE STRENGTH (Weight in kg x30) = mg dopamine made up to 12.5ml with 5% or 10% dextrose ml/hour= 4-20 microgram/kg/minute DILUENTS: Dextrose 5% Dextrose 10% Sodium chloride 0.9% KNOWN COMPATIBILITY: Adrenaline, amiodarone, dobutamine, fentanyl Gentamicin, heparin, midazolam, morphine, noradrenaline, pancuronium, potassium chloride, ranitidine, vecuronium 16

17 KNOWN INCOMPATIBILITIES: Alkaline solutions, aciclovir, amphotericin, ampicillin, benzylpenicillin, indomethacin, insulin, metronidazole, sodium bicarbonate, tolazoline, TPN SINGLETON HOSPITAL - NEONATAL UNIT DOPAMINE INFUSION VIA PERIPHERAL IV LINE Preparation: Infusion: Diluent: Please note: 40mg of Dopamine to be diluted to 25 ml of preferred diluent 5 microgram/kg/minute at a rate of 0.19 ml/kg/hr 10 microgram/kg/minute at a rate of 0.38 ml/kg/hr 15 microgram/kg/minute at a rate of 0.57 ml/kg/hr 20 microgram/kg/minute at a rate of 0.76 ml/kg/hr Dextrose 5%, Dextrose 10%, 0.9% normal saline 1. Dopamine should only be given peripherally in exceptional circumstances. 2. Maximum infusion concentration should not exceed 1.6 mg/ml via peripheral line. 3. For babies less than 1.3 kg, our current single and double strength dilutions are using dopamine less than 1.6 mg/ml limit. 17

18 HEPARIN solution For arterial lines PREPARATIONS: DILUTION: 0.5units/hour =0.5ml/hour (made up as below) Pre-filled syringes 50units heparin in 50ml of 0.45% sodium chloride To make on the unit - if pre-filled syringe not available Add 5ml (50units) of Hepsal to 45ml Sodium chloride 0.45% to give 50units in 50ml (1unit /ml) NB 0.45% sodium administers 0.9mmol of Na / 24 hours. This with 0.18mmol from heparin means baby gets 1mmol of Na /24 hrs by this route DILUENTS: Sodium chloride 0.45% Dextrose 5% Dextrose 10% KNOWN COMPATIBILITY: KNOWN INCOMPATIBILITIES: Aciclovir, adrenaline, benzylpenicillin, calcium gluconate, dopamine, fentanyl, frusemide, insulin, lipid, magnesium sulphate, metronidazole, morphine, noradrenaline, pancuronium, ranitidine, sodium bicarbonate, TPN, vecuronium Erythromycin, gentamicin, vancomycin 18

19 Hydrocortisone Hypotension in pre-term neonates. To reduce CLD and facilitate extubation Hypotension 1-2mg/kg bd for 3 days Facilitate extubation 1.25mg/kg qds for 7 days 0.9mg/kg qds for 5 days 0.6mg/kg qds for 5 days 0.3mg/kg qds for 5days Give as iv bolus over 3-5mins PREPARATIONS: DILUTION: Hydrocortisone sodium succinate 100mg Hydrocortisone in 2ml Reconstitute 100mg with diluents (water for injection) provided to give 100mg in 2ml.Further dilute 1ml to 10mlto give 5mg in 1ml DILUENTS: Sodium Chloride 0.9% Glucose 5% KNOWN COMPATIBILITIES: KNOWN INCOMPATIBILITIES: Dopamine, Frusemide, Morphine Midazolam, Phenytoin 19

20 -- INSULIN Plastic tubing used for infusion should be flushed with at least 20mls of insulin solution and primed by for at least 20 minutes before use because insulin binds to the tubing resulting in decreased availability to the baby. It is extremely important that any replacement set is also fully primed. Do not use the line to give any other medications e.g. antibiotics as this will result in a bolus of insulin with potentially significant hypoglycaemia. If there is only one peripheral cannula other infusions should be administered at the hub of the cannula. Insulin infusion Add 25 units/kg of insulin to 50 ml of i.v. solution, then infuse at 0.2 ml/hr (which equates to 0.1 units/kg/hr). Infuse at units/kg/hr. The following sliding scale is a recommendation, but may need adjusting to suit individual requirements. Blood Glucose Rate of infusion of solution >20 mmol/l 0.2ml/hr (0.1 units/kg/hr) 8 20 mmol/l 0.1 ml/hr (0.05 unit/kg/hr) < 8 mmol/l Stop insulin infusion If fluids are restricted a double strength infusion can be prepared by diluting 50 units/kg to 50 ml i.v. solution where 0.1 ml/hour = 0.1 unit/kg/hour. No more than 0.5 units/kg/hr is usually needed. Some growth retarded and very pre-term babies can be very sensitive to the effects of insulin so monitor blood glucose very frequently at the start of the infusion. Diluents: Sodium chloride (0.45% and 0.9%) and Dextrose 5% and 10%. The infusion should be freshly prepared every 24 hours. Vials of insulin should be stored in a refrigerator at 2 8 o C. Do not use if the solution appears hazy or coloured. Known compatibilities: Can be added (terminally) to a line containing: Dobutamine, Heparin, Midazolam, Milrinone, Morphine, Potassium, TPN (Aqueous), Vancomycin Known incompatibilities: Aminophylline, Phenytoin, Phenobarbitone, Dopamine, sodium bicarbonate 20

21 Liver medication for babies with conjugated jaundice Babies with neonatal cholestasis where the conjugated bilirubin fraction is greater than 50 umol/l will need additional supplements of fat soluble vitamins. This recommendation is adapted from the King s college, London guidelines 2009 for neonatal cholestatsis. Option 1: Dalavit 0.3 mls BD OR Abidec 0.3mls BD orally Vitamin E 10mg/Kg OD orally Vitamin K 1mg OD orally / intravenously Ursodeoxycholic acid 5-10mg/Kg TDS orally Option 2 (If medications in option 1 are not available): Ketovite liquid 5mls OD orally Ketovite tablet 3tab crushed along with Ketovite liquid Vitamin K 1mg OD orally / intravenously Ursodeoxycholic acid 5-10mg/Kg TDS orally In addition, for both options, you may consider Alfacalcidol 5-10nanogram/kg/day if you have confirmed evidence of Vitamin D deficiency. You will need close monitoring of serum calcium and phosphate levels. 21

22 PREPARATIONS: DILUTION: LEVETIRACETAM Treatment of seizures GIVE ONLY BY IV INFUSION OVER 15 MINS. *Loading dose of 30mg/kg iv followed after 12 hours by a maintenance dose of 10mg/kg iv/po bd. Levetiracetam 500mg in 5ml infusion Dilute 1ml to 10ml to give a concentration of 10mg in 1ml before administering. DILUENTS: Glucose 5% Sodium chloride 0.9% 22

23 SINGLETON HOSPITAL-NEONATAL UNIT MAGNESIUM SULPHATE Hypocalcaemia Hypomagnesaemia Persistent Pulmonary Hypertension Hypocalcaemia/Hypomagnesaemia Persistent Pulmonary Hypertension 100mg/kg by iv infusion This dose can be repeated every 12 hours as necessary for 2-3 doses Maximum infusion rate 10mg/kg/min Loading dose 200mg/kg over 20-30mins,if response occurs then by continuous infusion of 20-75mg/kg/hour to maintain plasma magnesium concentration between mmol/litre for 2-5days PREPARATIONS: Magnesium Sulphate 50% 10ml ampoule (contains 5g in 10ml) DILUTION: * Dilute to 100mg in 1ml before administration as follows* Draw up 2ml Magnesium Sulphate 50% and make up to 10ml with diluent to give a solution containing 100mg in 1ml Give required dose as infusion over 20-30minutes. For continuous infusion 20mg/kg/hour=0.2ml/kg/hour 23

24 DILUENTS: Dextrose 5%, sodium Chloride 0.9% KNOWN COMPATIBILITY: Insulin, morphine, TPN, Vancomycin KNOWN INCOMPATIBILITIES: Ambisome,dobutamine, metronidazole, salbutamol and sodium bicarbonate 24

25 Midazolam Anticonvulsant Initially microgram/kg over 5minutes followed by a continuous infusion of microgram/kg/hour PREPARATIONS: Many different concentrations and ampoule sizes. CHECK CAREFULLY DILUTION: DILUENTS: Dilute 15mg/kg body-weight to 50ml Infuse at 0.1ml/hour to give 30microgram/kg/hour Dextrose 5% Dextrose10% Sodium Chloride 0.9% KNOWN COMPATIBILITY: KNOWN INCOMPATIBILITY: Adrenaline,Calcium Gluconate,Dopamine,Fentanyl, Heparin,Morphine,Noradrenaline,Pancuronium. Potassium chloride,tpn Furosemide, Sodium bicarbonate,ranitidine 25

26 MORPHINE SULPHATE Sedation during ventilation IV Infusion 5-20micrograms/kg/hour Pre-intubation dose=50microgram/kg PREPARATIONS: Morphine suphate 500microgram in 10 ml Dextrose 5% DILUTION: See attached nomogram DILUENTS: Dextrose 5% Dextrose 10% Sodium chloride 0.9% KNOWN COMPATIBILITY: Adrenaline, Amiodarone, Dobutamine, Dopamine, Magnesium sulphate, Midazolam, Noradrenaline,Pancuronium, Potassium chloride, Ranitidine KNOWN INCOMPATIBILITIES: Alkaline solutions, Aciclovir, Frusemide,Heparin, Sodium bicarbonate 26

27 MORPHINE SYRINGES 50 MICROGRAMS PER 1ML DEXTROSE 5% Baby s Weight 5 mcg/kg/hr 10 mcg/kg/hr 20 mcg/kg/hr 0.5 kg - 0.1ml/hr 0.2ml/hr 0.75 kg 0.1 ml/hr 0.15ml/hr 0.3ml/hr 1.0 kg 0.1ml/hr 0.2ml/hr 0.4ml/hr 1.25 kg 0.12 ml/hr 0.25ml/hr 0.5ml/hr 1.5 kg 0.15 ml/hr 0.3ml/hr 0.6ml/hr 1.75 kg 0.17ml/hr 0.35ml/hr 0.7ml/hr 2.0 kg 0.2ml/hr 0.4ml/hr 0.8ml/hr 2.25 kg 0.22ml/hr 0.45ml/hr 0.9ml/hr 2.5 kg 0.25ml/hr 0.5ml/hr 1.0ml/hr 2.75 kg 0.27ml/hr 0.55ml/hr 1.1ml/hr 3.0 kg 0.3ml/hr 0.6ml/hr 1.2ml/hr 3.25 kg 0.32ml/hr 0.65ml/hr 1.3ml/hr 3.5 kg 0.35ml/hr 0.7ml/hr 1.4ml/hr 3.75 kg 0.37ml/hr 0.75ml/hr 1.5ml/hr 4.0 kg 0.4ml/hr 0.8ml/hr 1.6ml/hr **For intermediate weights - round up or down to the nearest specified weight in the table. PRE-INTUBATION (ONLY FOR ELECTIVE INTUBATION) 50 micrograms/kg BOLUS (1 ml/kg) NOTE : Syringes are unable to infuse at rates < 0.1 ml/hr 27

28 PREPARATIONS: DILUTION: NORADRENLINE Vasoconstrictor to treat hypotension VIA A CENTRAL LINE nanograms/kg/min noradrenaline base adjusted according to response. Max 1.5microgram/kg/minute Noradrenaline acid tartrate 2mg in 1ml equivalent to Noradrenaline BASE 1mg in 1ml Weight in kg x 1.5 = mg noradrenaline base made up to 25ml with dextrose 10% DILUENTS: Dextrose 5% Dextrose 10% 0.1ml/hour=100nanogram/kg/minute Protect infusion from light Discard solution if brown colour develops KNOWN COMPATIBILITY: KNOWN INCOMPATIBILITIES: Adrenaline, calcium gluconate, dobutamine dopamine, fentanyl, heparin, magnesium sulphate, midazolam, morphine,potassium chloride, TPN Insulin, lignocaine, sodium bicarbonate 28

29 PREPARATIONS: TAZOCIN (Piperacillin with tazobactam) Broad spectrum antibiotic See Neonatal Formulary AS IV Bolus over 3-5mins or infusion over 30mins Injection 2.25g vial NB 1g contains 2mmol Na (Tazocin) Manufacturers; Sandoz,Pfizer Wockhardt Actavis,Noridem Fresenius Kabi DILUTION: Displacement value 2.25g=1.58ml Add 8.4ml Water for Injection or Sodium chloride 0.9% to 2.25g vial to give a concentration of 225mg in 1ml For infusion further dilute above solution to at least 90mg in 1ml and give over 30mins Piperacillin/Tazobactam (Bowmed,Stragen) Displacement value 2.25g=1.7ml Add 8.3ml Water for Injection or Sodium chloride 0.9% to 2.25g vial to give a concentration of 225mg in 1ml For infusion further dilute above solution To at least 90mg in 1ml and give over 30mins 29

30 THAM (tris-hydroxymethyl aminomethane/ trometamol, tromethamine) Metabolic acidosis when sodium bicarbonate inappropriate Calculate total no. of mmol of bicarbonate required for half correction 0.3 base deficit (mmol/litre) weight (Kg) 1mmol of bicarbonate = 1ml of 7.2% THAM = 1 ml of 8.4% sodium bicarbonate Give over 30 minutes or longer PREPARATIONS: 5mL ampoule containing THAM 7.2% DILUTION: Dilute THAM 7.2% to 3.6% Concentration using an equal volume of dextrose 5% or water for injection If necessary, fluid restricted patients may be given THAM 7.2% undiluted via a long line or central line DILUENTS: Dextrose 5% Water for injection KNOWN INCOMPATIBILITIES: Benzylpenicillin 30

31 PREPARATIONS: VECURONIUM Non depolarising muscle relaxant used in ventilation IV BOLUS Initially microgram/kg then 30-50microgram/kg adjusted according to response, usually every 2-4hours IV INFUSION 50-80microgram/kg/hour 10mg vecuronium powder with 5ml water for injection to give a solution of 2mg in 1ml DILUTION: SINGLE STRENGTH (Weight in Kg x5) =mg of vecuronium made up to 50ml with 5% dextrose 0.5-1ml/hr=50-100microgram/kg/hr DOUBLE STRENGTH (Weight in Kg x10)=mg of vecuronium made up to 50ml with 5% dextrose ml/hr=50-100microgram/kg/hr QUADRUPLE STRENGTH (Weight in Kg x20)=mg of vecuronium made up to 50 ml with 5% dextrose ml/hr=50-100microgram/kg/hour DILUENTS: 5% dextrose 10% dextrose 0.9% sodium chloride 0.45% sodium chloride 31

32 KNOWN COMPATIBILITY: Adrenaline,Aminophylline, Dopamine,, Dobutamine, Fentanyl, Heparin, Hydrocortisone, Midazolam, Morphine,Noradrenaline, Ranitidine, Vancomycin KNOWN INCOMPATIBILITIES: Diazepam, Frusemide, Sodium bicarbonate Checked by Katherine Willson: Neonatal Pharmacist, January

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES Transport Medication List Title of policy: Transport Medication List Date Revised:

More information

Common Infusions for Neonatal Use

Common Infusions for Neonatal Use Common Infusions for Neonatal Use Document Title and Reference : Common Infusions for Neonatal Use Main Author (s) Dr N B Soni Ratified by: LSC CEG Date Ratified: May 2016 Review Date: May 2018 Version:

More information

ADENOSINE. ADRENALINE (Epinephrine)

ADENOSINE. ADRENALINE (Epinephrine) ADENOSINE Notes Arrhythmias I.V. Initial dose 150 micrograms/kg stat Increase dose if required by 50 micrograms/kg to a maximum of 300 micrograms/kg (or 500 micrograms/kg if over 28 days old) ADMINISTRATION

More information

Resuscitation Fluids

Resuscitation Fluids Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be

More information

Cardiac Catheter Labs Intravenous Drug Therapy Guide

Cardiac Catheter Labs Intravenous Drug Therapy Guide Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

INTRAVENOUS FLUIDS PRINCIPLES

INTRAVENOUS FLUIDS PRINCIPLES INTRAVENOUS FLUIDS PRINCIPLES Postnatal physiological weight loss is approximately 5-10% Postnatal diuresis is delayed in Respiratory Distress Syndrome (RDS) Preterm babies have limited capacity to excrete

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

INTRAVENOUS THERAPY INSTRUCTIONAL PACKAGE

INTRAVENOUS THERAPY INSTRUCTIONAL PACKAGE INTRAVENOUS THERAPY INSTRUCTIONAL PACKAGE WORKBOOK FOR THE CALCULATION OF FLOW RATES AND MEDICATION DOSAGES January 2014 WORKBOOK C O N T E N T S Page Professional Responsibilities 3 Methods for flowrate

More information

Critical Care Standard Infusion Concentrations

Critical Care Standard Infusion Concentrations Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in

More information

INTRAVENOUS FLUID THERAPY

INTRAVENOUS FLUID THERAPY INTRAVENOUS FLUID THERAPY PRINCIPLES Postnatal physiological weight loss is approximately 5 10% in first week of life Preterm neonates have more total body water and may lose 10 15% of their weight in

More information

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/

More information

Medication Calculation Practice Problems

Medication Calculation Practice Problems Medication Calculation Practice Problems Below is a section of the list of medications that are programmed in the Alaris IV Pump s Guardrail Drug Library. During your orientation you will learn more about

More information

CICU STANDARD INTRAVENOUS INFUSIONS CHART

CICU STANDARD INTRAVENOUS INFUSIONS CHART IU STANDARD INTRAVENOUS INFUSIONS HART Full Title of uideline: Author (include email and role): Division & Speciality: Version: 2 Ratified by: Scope (Target audience, state if Trust wide): Review date

More information

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211 Math for Meds College of Southern Nevada Nursing 211 Name: Date: Directions: 1. Solve the dosage calculation problems utilizing the method of your choice. 2. Show your work! 3.Divide math out to the thousandth

More information

CLINICAL GUIDELINES ANTIBIOTIC GUIDELINES FOR NEONATES AND PAEDIATRICS. Register No: Review of Guideline. Contributes to Core Standards No

CLINICAL GUIDELINES ANTIBIOTIC GUIDELINES FOR NEONATES AND PAEDIATRICS. Register No: Review of Guideline. Contributes to Core Standards No ANTIBIOTIC GUIDELINES FOR NEONATES AND PAEDIATRICS CLINICAL GUIDELINES Register No: 08066 Developed in response to: Contributes to Core Standards No Best clinical practice Review of Guideline C5a Consulted

More information

DR J HARTY / DR CM RITCHIE / DR M GIBBONS

DR J HARTY / DR CM RITCHIE / DR M GIBBONS CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Postop, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe) Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension

More information

Protocol for Ferric Carboxymaltose (Ferinject ) Injection Use in Paediatric Services

Protocol for Ferric Carboxymaltose (Ferinject ) Injection Use in Paediatric Services Procol for Ferric Carboxymalse (Ferinject ) Injection Use in Paediatric Services Specialty: Paediatric Services Date Approved: 19 th March 2014 Approved by: W&CH Quality & Safety Group Date for Review:

More information

IV drug preparation guidelines. Prepared by pharmacist Eman Elayeh

IV drug preparation guidelines. Prepared by pharmacist Eman Elayeh IV drug preparation guidelines Prepared by pharmacist Eman Elayeh Injectable drugs guide The monographs in this book detail appropriate methods of administration for medicines that can be given via the

More information

TOTAL PARENTERAL NUTRITION

TOTAL PARENTERAL NUTRITION TOTAL PARENTERAL NUTRITION Indication See algorithm. Timing Start TPN as indicated on algorithm 1. There is no need to build up TPN volume. The volume of TPN (including lipids) should equate to the total

More information

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist CLINICAL GUIDELINES ID TAG Title: Author: Designation: Speciality / Division: Directorate: Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick

More information

CHILDREN S SERVICES. Guidelines for the Management of Meningococcal Septicaemia

CHILDREN S SERVICES. Guidelines for the Management of Meningococcal Septicaemia 1 CHILDREN S SERVICES Guidelines for the Management of Meningococcal Septicaemia Please note these are guidelines only and it will be the clinician s discretion to apply different treatment depending on

More information

Guideline for Management of Severe or Fulminating Pre-Eclampsia

Guideline for Management of Severe or Fulminating Pre-Eclampsia Guideline for Management of Severe or Fulminating Pre-Eclampsia Originator: Labour Ward Forum, Maternity Services Date Approved: September 2011 Approved by: W&CH Quality & Safety Group Reviewed and ratified

More information

Pre arrival of the retrieval team

Pre arrival of the retrieval team Pre arrival of the retrieval team Notes photocopied Nasogastric/Orogastric tube in place if child is ventilated Chest x ray if applicable IV access x 2 if possible Recent blood glucose Recent temperature

More information

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the

More information

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name

More information

LET - Maths, Stats & Numeracy

LET - Maths, Stats & Numeracy Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than

More information

Fluid & Electrolyte Balances in Term & Preterm Infants. Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital

Fluid & Electrolyte Balances in Term & Preterm Infants. Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital Fluid & Electrolyte Balances in Term & Preterm Infants Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital Objectives Review maintenance fluid & electrolyte requirements in neonates Discuss

More information

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5)

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5) (Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed (if applicable): Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Donor CMV

More information

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy 1. Purpose Magnesium sulphate is the anticonvulsant of choice for pre-eclampsia prophylaxis and treatment. This clinical guideline outlines the indications, contraindications, administration and monitoring

More information

Assessing a patient in an Emergency useful tips and drug doses Programme

Assessing a patient in an Emergency useful tips and drug doses Programme Assessing a patient in an Emergency useful tips and drug doses 2015-2016 Programme sing a Patient in an Emergency: Immediate Actions to be taken Are there any signs of life? If No commence BLS If Yes assess

More information

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text]

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text] Clinical Manual Part 4 Standard Drug List Version 8.1 July 2018 [Type text] Royal Flying Doctor Service Western Operations 3 Eagle Drive, Jandakot Airport, Western Australia 6164 T 61-8-9417 6300 F 61-8-9417

More information

Good practice for drug calculations

Good practice for drug calculations Good practice for drug calculations A step-by-step guide for nurses, doctors and all other healthcare professionals Pharmacyservices 7048 Drug Cal Guide A6 Update_AW.indd 1 22/07/2014 09:55 2 Contents

More information

PARENTERAL NUTRITION

PARENTERAL NUTRITION PARENTERAL NUTRITION DEFINITION Parenteral nutrition [(PN) or total parenteral nutrition (TPN)] is the intravenous infusion of some or all nutrients for tissue maintenance, metabolic requirements and growth

More information

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:

More information

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Author: Contact Name and Job Title.

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Author: Contact Name and Job Title. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Author: Contact Name and Job Title of Fluid and Electrolytes in Neonates D2 (prev.d14) Version 3 : Dr. Ai May Lee,

More information

Printed copies of this document may not be up to date, obtain the most recent version from

Printed copies of this document may not be up to date, obtain the most recent version from Children s Acute Transport Service Clinical Guidelines Septic Shock Document Control Information Author Claire Fraser P.Ramnarayan Author Position tanp CATS Consultant Document Owner E. Polke Document

More information

DRUGS FOR VIVA. IAP UG Teaching slides

DRUGS FOR VIVA. IAP UG Teaching slides DRUGS FOR VIVA 1 Q:1 INJ SODIUM BICARBONATE 1. What all strengths are available? 2. What are the clinical indications for IV sodium bicarbonate? 3. How do you administer this drug? 2 ANS: 1. Available

More information

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5 HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter

More information

Basic Fluid and Electrolytes

Basic Fluid and Electrolytes Basic Fluid and Electrolytes Chapter 22 Basic Fluid and Electrolytes Introduction Infants and young children have a greater need for water and are more vulnerable to alterations in fluid and electrolyte

More information

Selected Clinical Calculations Chapter 10. Heparin-Dosing calculations

Selected Clinical Calculations Chapter 10. Heparin-Dosing calculations Selected Clinical Calculations Chapter 10 Heparin-Dosing calculations Heparin is a heterogeneous group of muco-polysaccharides that have anticoagulant properties (slows clotting time). Heparin salt, as

More information

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code (Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed: Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Recipient CMV status Donor

More information

NUTRITIONAL REQUIREMENTS

NUTRITIONAL REQUIREMENTS NUTRITION AIMS To achieve growth and nutrient accretion similar to intrauterine rates To achieve best possible neurodevelopmental outcome To prevent specific nutritional deficiencies Target population

More information

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost

More information

Module 8: Practice Problems

Module 8: Practice Problems Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,

More information

Nonparenteral medications

Nonparenteral medications Nonparenteral medications Capsules and unscored tablets are rounded to the nearest whole tablet. Scored tablets are rounded to the nearest 1/2 tablet. Liquid medications are rounded to one decimal place

More information

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006) When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032

More information

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

Analgesia and Sedation Guidelines for Paediatric Intensive Care Unit

Analgesia and Sedation Guidelines for Paediatric Intensive Care Unit These clinical guidelines have been developed by a multidisciplinary working group in an attempt to achieve consistency in the choice and application of analgesic and sedative drugs in the PICU/CICU including

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Cisatracurium 2 mg/ml Solution for injection/ infusion Cisatracurium 5 mg/ml Solution for injection/ infusion Cisatracurium The name of your medicine are Cisatracurium

More information

Guideline for the use of Clonidine for Sedation in Adult Intensive Care

Guideline for the use of Clonidine for Sedation in Adult Intensive Care Guideline for the use of Clonidine for Sedation in Adult Intensive Care This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the

More information

Paediatric Anticoagulant Guidelines. Bhavee Patel, Gareth Thomas

Paediatric Anticoagulant Guidelines. Bhavee Patel, Gareth Thomas Paediatric Anticoagulant Guidelines Author: Bhavee Patel, Gareth Thomas Specialty: Paediatrics Date Approved: 18 th July 2012 Approved by: W&CH Quality & Safety Group Date for Review: June 2015 PAEDIATRIC

More information

PHARMACOLOGY AND PHARMACOKINETICS

PHARMACOLOGY AND PHARMACOKINETICS DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate PACKAGE LEAFLET: INFORMATION FOR THE USER Dopamine 40 mg/ml Sterile Concentrate Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.

More information

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of

More information

NICU Nutrition Pathway

NICU Nutrition Pathway NICU Nutrition Pathway Safely Infusing NICU TPN Starter and Custom TPN April17 th 2018 Pharmacists: Paul Kasprzak RPH BCPS Kelly Kopec PharmD Major Practice Changes in the Preparation and Administration

More information

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING. Patient Status Pt Status: Inpatient (Inpatient only

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.

More information

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Paediatric Prescribing Pocket Guide September 2014 (Version 1) PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Clinical Manual. Part 2 Drug Infusion Guidelines

Clinical Manual. Part 2 Drug Infusion Guidelines Clinical Manual Part 2 Drug Infusion Guidelines Version 8.0 August 2018 Royal Flying Doctor Service Western Operations 3 Eagle Drive, Jandakot Airport, Western Australia 6164 T 61-8-9417 6300 F 61-8-9417

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion Cisatracurium Read all of this leaflet carefully before

More information

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane Systemic Anti Cancer Treatment Protocol EDP + mitotane PROCEDURE REF: MPHAHANEDP (Version No: 1.0) Approved for use in: Symptomatic treatment for advanced (unresectable, metastatic or relapsed) adrenocortical

More information

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart September 14 V0.17 Aims and outcomes of session. Aim: To provide guidance on correctly completing the paediatric daily fluid prescription & balance chart. Outcomes: Demonstrate the ability to: calculate

More information

Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children

Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children Link to: Adult Nebuliser Guidelines Link to: Paediatric Nebuliser Guidelines and Monographs ANTIBIOTICS/

More information

Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015)

Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015) Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015) BCU Citrate Guideline v6 Nov 2015 (Approved by CCSC May 15) 1 BCU Critical Care Guideline for Renal Replacement Therapy

More information

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score

More information

48 th Annual Meeting. A Review of Pharmacy Calculations for Pharmacy Technicians. Metric System of Measurement. Disclosure. Common Conversions

48 th Annual Meeting. A Review of Pharmacy Calculations for Pharmacy Technicians. Metric System of Measurement. Disclosure. Common Conversions 48 th Annual Meeting A Review of Pharmacy Calculations for Pharmacy Technicians Nina Pavuluri, Ph.D. Navigating the Oceans of Opportunity Metric System of Measurement Base Unit Factor Name Symbol 1 (g,

More information

Tumour Lysis Syndrome (TLS)

Tumour Lysis Syndrome (TLS) (TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you

More information

SOP for the Prescribing and Administration of Milrinone on The Children s Heart Centre

SOP for the Prescribing and Administration of Milrinone on The Children s Heart Centre SOP for the Prescribing and Administration of Milrinone on The Children s Heart Centre Version Number 2 Date of Issue July 2017 Reference Number PAMCHC-07-2017-MHPLMLAGOFSSDS-V2 Review Interval Approved

More information

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title

More information

Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013

Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013 Index No: Intravenous fluid prescription in children For previously well children aged one month to 16 years (excluding renal, cardiac, diabetic ketoacidosis and acute burns patients) Version: 1 Date ratified:

More information

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy) DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE

More information

DOCUMENT CONTROL PAGE

DOCUMENT CONTROL PAGE DOCUMENT CONTROL PAGE Title Title: UNDERGOING SPINAL DEFORMITY SURGERY Version: 2 Reference Number: Supersedes Supersedes: all other versions Description of Amendment(s): Revision of analgesia requirements

More information

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER

More information

PACKAGE LEAFLET. Package leaflet: Information for the user. Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion.

PACKAGE LEAFLET. Package leaflet: Information for the user. Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion. PACKAGE LEAFLET Package leaflet: Information for the user Vancomycin Hospira 500 mg Powder for concentrate for solution for infusion Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion

More information

Guideline for the Post Operative Management of Women who have received Intrathecal or Epidural Opioid Analgesia for Caesarean Section

Guideline for the Post Operative Management of Women who have received Intrathecal or Epidural Opioid Analgesia for Caesarean Section Guideline for the Post Operative Management of Women who have received Intrathecal or Epidural Opioid Analgesia for Caesarean Section Speciality: Maternity Approval Body: Labour Ward Forum Approval Date:

More information

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:. - Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating

More information

The Jessop Wing, Sheffield Teaching Hospitals NHS Trust

The Jessop Wing, Sheffield Teaching Hospitals NHS Trust 1 The Jessop Wing, Sheffield Teaching Hospitals NHS Trust Neonatal Formulary (9 th Edition) This formulary has been compiled to accurately reflect prescribing practise on the neonatal unit at the Jessop

More information

Nutrition Care Process: Case Study B Examples of Charting in Various Formats

Nutrition Care Process: Case Study B Examples of Charting in Various Formats Nutrition Care Process: Case Study B Examples of Charting in Various Formats Case: JG is a 68 year old woman with a history of type 2 diabetes, chronic renal failure which is treated with hemodialysis

More information

Zzbeacon,Zayna [MR ]

Zzbeacon,Zayna [MR ] AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release

More information

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there

More information

DONATION AFTER CARDIAC DEATH PLAN

DONATION AFTER CARDIAC DEATH PLAN DONATION AFTER CARDIAC DEATH PLAN Diagnosis Weight Allergies Patient Care Core Body Temperature Monitoring Maintain body temp 96-99 degrees Farenheit. Utilize Hyper/Hypothermia blanket prn Insert Gastric

More information

Physician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies

Physician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies Height: cm Weight: kg Allergies: [ ] No known allergies [ ] Initiate Powerplan Phase T;N, Phase: LEB PICU Admit Phase Admission/Transfer/Discharge [ ] Admit Patient to Dr. [ ] Admit Status: [ ] Inpatient

More information

Duct Dependant Congenital Heart Disease

Duct Dependant Congenital Heart Disease Children s Acute Transport Service Clinical Guidelines Duct Dependant Congenital Heart Disease Document Control Information Author CATS/NTS Author Position CC Transport Services Document Owner E. Polke

More information

Duct Dependant Congenital Heart Disease

Duct Dependant Congenital Heart Disease Children s Acute Transport Service Clinical Guidelines Duct Dependant Congenital Heart Disease This guideline has been agreed by both NTS & CATS Document Control Information Author CATS/NTS Author Position

More information

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD) Date: Time: = Always applicable = Check if applicable ADMISSION INSTRUCTIONS Move to Comfort Care Note in chart. Contact initiated with BC Transplant Consent for Organ Donation obtained Code Status: Full

More information

I write in response to your request for information in relation to pharmacy drug guidelines within NHS Lothian.

I write in response to your request for information in relation to pharmacy drug guidelines within NHS Lothian. Lothian NHS Board = Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG = Telephone: 0131 536 9000 www.nhslothian.scot.nhs.uk www.nhslothian.scot.nhs.uk Dear FREEDOM OF INFORMATION IV POLICIES Date: 03/10/2016

More information

Flagyl and lactated ringers compatibility

Flagyl and lactated ringers compatibility Flagyl and lactated ringers compatibility When reconstituted as Metronidazole IV for Infusion, it has... mmol/l and 40 mmol/l. While physically compatible with Compound Sodium Lactate. Infusion ( Hartmann's

More information

DERBY-BURTON LOCAL CANCER NETWORK FILENAME R-CODOX-M.DOC CONTROLLED DOC NO: HCCPG B115 CSIS Regimen Name: R-CODOXM. Rituximab + CODOX-M

DERBY-BURTON LOCAL CANCER NETWORK FILENAME R-CODOX-M.DOC CONTROLLED DOC NO: HCCPG B115 CSIS Regimen Name: R-CODOXM. Rituximab + CODOX-M Rituximab + CODOX-M Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Indication Burkitt

More information

GUIDELINE FOR THE POST OPERATIVE MANAGEMENT OF WOMEN WHO HAVE RECEIVED INTRATHECAL OR EPIDURAL OPIOID ANALGESIA FOR CAESAREAN SECTION

GUIDELINE FOR THE POST OPERATIVE MANAGEMENT OF WOMEN WHO HAVE RECEIVED INTRATHECAL OR EPIDURAL OPIOID ANALGESIA FOR CAESAREAN SECTION GUIDELINE FOR THE POST OPERATIVE MANAGEMENT OF WOMEN WHO HAVE RECEIVED INTRATHECAL OR EPIDURAL OPIOID ANALGESIA FOR CAESAREAN SECTION Originator: Maternity Services & Anaesthetics Dept Date Approved: January

More information

PROTOCOL FOR PARENTERAL NUTRITION

PROTOCOL FOR PARENTERAL NUTRITION PROTOCOL FOR PARENTERAL NUTRITION Based on; Roberton s textbook of neonatology. 4 th edition. 2005. Sudha Chaudari and Sandeep Kumar.TPN in neonates. Indian Paediatrics. November 2006 Deepak Chawla, Anu

More information

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment.

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment. Notes REGISTRATION ASSESSMENT SITTINGS 2018 Part 1 example questions 1. Questions 1 to 12 are examples from part 1 of the registration assessment. 2. The answers are on page 14. 3. Unless specified, give

More information